460 related articles for article (PubMed ID: 24815381)
1. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
[TBL] [Abstract][Full Text] [Related]
2. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
Kjær SK; Munk C; Junge J; Iftner T
Cancer Causes Control; 2014 Feb; 25(2):179-89. PubMed ID: 24242002
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
5. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
[TBL] [Abstract][Full Text] [Related]
7. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
8. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
[TBL] [Abstract][Full Text] [Related]
14. Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.
Mesher D; Panwar K; Thomas SL; Beddows S; Soldan K
BMJ Open; 2016 Feb; 6(2):e009915. PubMed ID: 26868944
[TBL] [Abstract][Full Text] [Related]
15. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?
Panatto D; Amicizia D; Tanzi E; Bianchi S; Frati ER; Zotti CM; Lai PL; Bechini A; Rossi S; Gasparini R
BMC Infect Dis; 2013 Dec; 13():575. PubMed ID: 24313984
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for intervention.
Guido M; Tinelli A; De Donno A; Bruno AR; Tagliaferro L; Fedele A; Carbone A; Menegazzi P; Aprile V; Greco M; Malvasi A; Piccinni MA; Turano S; Grima P; Dell' Ederam D; Zizza A
Curr Pharm Des; 2013; 19(8):1498-507. PubMed ID: 23016783
[TBL] [Abstract][Full Text] [Related]
18. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study.
Učakar V; Poljak M; Klavs I
Vaccine; 2012 Jan; 30(2):116-20. PubMed ID: 22080175
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
Alemany L; Pérez C; Tous S; Llombart-Bosch A; Lloveras B; Lerma E; Guarch R; Andújar M; Pelayo A; Alejo M; Ordi J; Klaustermeier J; Velasco J; Guimerà N; Clavero O; Castellsagué X; Quint W; Muñoz N; Bosch FX; de Sanjosé S;
Gynecol Oncol; 2012 Mar; 124(3):512-7. PubMed ID: 22119990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
